Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Divalproex Sodium NDC 16714-485 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a figure showing the reduction in CPS rate of patients receiving Divalproex Sodium Delayed-Release Tablets compared to placebo. The figure depicts that 50% of patients showed improvement in their condition while some showed no change or worsening. There is no further information available in the text.*
The text describes a figure labeled as Figure 2 that shows the percentage reduction in CPS rate for patients taking high and low doses of Divalproex Sodium Delayed-Release Tablets. The figure shows that 50% of patients had shown improvement while some patients had shown No change or worsening of their conditions.*
This is a list of some numerical values and a medication name "Divalproex Sodium Extended-Release Tablets", but there is not enough context to provide a useful description.*
This is a description of a medication for oral administration, in the form of a film-coated tablet. It contains Divalproex sodium, which is equivalent to valproic acid, at a concentration of 250mg. The medication has extended release properties and is to be taken once daily, with dosage instructions provided in an enclosed document. The medication should be stored between 20-25°C (68-77°F), dispensed in a tightly sealed container, and not accepted if the bottle seal is broken or missing. The medication should be accompanied by a medication guide which is available through a phone number, and the tablets are manufactured by Aurobindo Pharma Limited. The size of the tablets is 130 x 50 mm, and NDC code is 16714-484-01.*
This is a medication for which each extended-release tablet contains 500 mg of Divalproex sodium USP equivalent to Valproic acid. The recommended dosage can be found in the enclosure provided with the medication. The drug is manufactured by Aurobindo Pharma Limited in Mahabubnagar, India, and distributed by Northstar Rx LLC in Memphis, TN. The tablets should be kept in a tightly sealed, light-resistant container at room temperature. A Medication Guide is provided separately to each patient and pharmacists should dispense it with the medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.